Clinical Trial Update: Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study evaluating ivabradine to reduce elevated heart rate in patients with multiple organ dysfunction syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Organ Dysfunction Syndrome

Drugs mentioned

• IVABRADINE

Snippet

Sponsor: Martin-Luther-Universität Halle-Wittenberg | Conditions: Multiple Organ Dysfunction Syndrome | Phase 2 | Status: UNKNOWN